| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.274.24.16694 |
| P8608 | Fatcat ID | release_22ygku5iercg5ctbfsqef56vzq |
| P3181 | OpenCitations bibliographic resource ID | 1143834 |
| P698 | PubMed publication ID | 10358008 |
| P5875 | ResearchGate publication ID | 12940944 |
| P50 | author | Brian Kobilka | Q80907 |
| Edwin A. Schauble | Q61018348 | ||
| P2093 | author name string | D. Bernstein | |
| D. K. Rohrer | |||
| K. H. Desai | |||
| A. J. Chruscinski | |||
| P2860 | cites work | Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: The Bergen Blood Pressure Study | Q48026232 |
| Non-injection methods for the production of embryonic stem cell-embryo chimaeras | Q59092151 | ||
| The beta 1-adrenoceptor antagonist CGP 20712 A unmasks beta 2-adrenoceptors activated by (-)-adrenaline in rat sinoatrial node | Q69885141 | ||
| Estimation of body fat in normal and obese mice | Q71178082 | ||
| Differentiation of receptors responsive to isoproterenol | Q72314142 | ||
| Effect of beta-adrenergic blockade on lactate turnover in exercising dogs | Q72596002 | ||
| Molecular characterization of the human beta 3-adrenergic receptor | Q24320014 | ||
| Cloning of the cDNA for the human beta 1-adrenergic receptor | Q24633148 | ||
| Isoproterenol response following transfection of the mouse beta 2-adrenergic receptor gene into Y1 cells | Q28587893 | ||
| Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects | Q28592167 | ||
| Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors | Q28593314 | ||
| Derivation of completely cell culture-derived mice from early-passage embryonic stem cells | Q29547491 | ||
| Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice | Q29547898 | ||
| Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin | Q34684390 | ||
| Differentiation of Receptor Systems activated by Sympathomimetic Amines | Q34706728 | ||
| Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension | Q35751337 | ||
| The classification of beta-adrenoceptors in isolated ring preparations of canine coronary arteries | Q36003650 | ||
| Beta-adrenergic receptor alterations in hypertension--physiological and molecular correlates. | Q39161570 | ||
| Effect of beta-adrenergic blockade on biochemical and metabolic response to exercise | Q39361822 | ||
| Plasma catecholamines and essential hypertension. An analytical review | Q40144106 | ||
| Structure and function of the beta 3-adrenergic receptor | Q41455785 | ||
| Sympathetic nerve stimulation activates both beta 1- and beta 2-adrenoceptors of SA and AV nodes in anesthetized dog hearts | Q42601538 | ||
| Characterization of beta-adrenoceptor subtype in isolated ring preparations of intramural rat coronary small arteries. | Q46767659 | ||
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | regulation of heart rate | Q14820871 |
| regulation of the force of heart contraction | Q14865584 | ||
| norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure | Q14916354 | ||
| Adrenergic receptor, beta 2 | Q14916386 | ||
| P304 | page(s) | 16694–16700 | |
| P577 | publication date | 1999-06-11 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Targeted disruption of the beta2 adrenergic receptor gene | |
| P478 | volume | 274 |
| Q64934471 | A Dual Noradrenergic Mechanism for the Relief of Neuropathic Allodynia by the Antidepressant Drugs Duloxetine and Amitriptyline. |
| Q34625018 | A genetic analysis of opioid-induced hyperalgesia in mice |
| Q43728970 | A genetically engineered cell-based biosensor for functional classification of agents |
| Q39905040 | A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1. |
| Q44340993 | Adaptive immunity in mice lacking the beta(2)-adrenergic receptor |
| Q27307852 | Administration of a selective β2 adrenergic receptor antagonist exacerbates neuropathology and cognitive deficits in a mouse model of Alzheimer's disease |
| Q37776088 | Adrenergic Signaling Polymorphisms and Their Impact on Cardiovascular Disease |
| Q35073471 | Age-related changes in vascular adrenergic signaling: clinical and mechanistic implications |
| Q34252924 | Age-related impairment in insulin release: the essential role of β(2)-adrenergic receptor |
| Q28078697 | Altered pharmacological effects of adrenergic agonists during hypothermia |
| Q35983075 | Anabolic action of parathyroid hormone regulated by the β2-adrenergic receptor. |
| Q46843780 | Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans |
| Q34637468 | Autonomic control of blood pressure in mice: basic physiology and effects of genetic modification |
| Q35044789 | Beta 2 adrenergic receptor 5' haplotypes influence promoter activity |
| Q28594362 | Beta(1)/beta(2)/beta(3)-adrenoceptor knockout mice are obese and cold-sensitive but have normal lipolytic responses to fasting |
| Q49920938 | Beta-2 adrenergic receptors increase TREG cell suppression in an OVA-induced allergic asthma mouse model when mice are moderate aerobically exercised. |
| Q54380413 | Beta-2 adrenoreceptor gene polymorphisms and sympathetic outflow in humans. |
| Q34390762 | Beta-adrenergic axis and heart disease |
| Q41954109 | Beta-adrenergic receptor signaling in cardiac function and heart failure |
| Q54448921 | Beta-adrenergic signals regulate cardiac differentiation of mouse embryonic stem cells via mitogen-activated protein kinase pathways. |
| Q37406363 | Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction |
| Q36978985 | Beta2-adrenergic receptor signaling mediates corneal epithelial wound repair |
| Q24646260 | Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model |
| Q42943914 | Beta2-adrenoceptors and non-beta-adrenoceptors mediate effects of BRL37344 and clenbuterol on glucose uptake in soleus muscle: studies using knockout mice |
| Q37798966 | Beta3-adrenergic receptors in cardiac and vascular tissues emerging concepts and therapeutic perspectives. |
| Q36575695 | Bidirectional cross-regulation between ErbB2 and β-adrenergic signalling pathways |
| Q37941005 | Biochemical and molecular aspects of vascular adrenergic regulation of blood pressure in the elderly |
| Q34577717 | Bone marrow CD169+ macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche |
| Q35842857 | Cardiac GPCRs: GPCR signaling in healthy and failing hearts |
| Q48118068 | Cardiac RKIP induces a beneficial β-adrenoceptor-dependent positive inotropy. |
| Q35395744 | Cardiac pressure overload hypertrophy is differentially regulated by β-adrenergic receptor subtypes |
| Q28593314 | Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors |
| Q30332704 | Cardiovascular and renal phenotyping of genetically modified mice: a challenge for traditional physiology. |
| Q24317444 | Cart overexpression is the only identifiable cause of high bone mass in melanocortin 4 receptor deficiency |
| Q44049937 | Caveolar localization dictates physiologic signaling of beta 2-adrenoceptors in neonatal cardiac myocytes |
| Q89655632 | Cell-intrinsic adrenergic signaling controls the adaptive NK cell response to viral infection |
| Q42458186 | Changes in the vascular beta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats |
| Q37660869 | Chemotherapy-induced bone marrow nerve injury impairs hematopoietic regeneration. |
| Q44820578 | Chronic beta-adrenoreceptor stimulation in vivo decreased Bcl-2 and increased Bax expression but did not activate apoptotic pathways in mouse heart |
| Q51364201 | Chronic ritodrine treatment induces refractoriness of glucose-lowering β2 adrenoceptor signal in female mice. |
| Q43005856 | Clenbuterol induces cardiac myocyte hypertrophy via paracrine signalling and fibroblast-derived IGF-1. |
| Q43263994 | Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium |
| Q36384788 | Compartmentalization of beta-adrenergic signals in cardiomyocytes |
| Q33930463 | Cooperation of beta(2)- and beta(3)-adrenergic receptors in hematopoietic progenitor cell mobilization |
| Q52631071 | Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals. |
| Q31148387 | Degenerate suppression PCR identifies the beta2-adrenergic receptor as upregulated by neuronal differentiation |
| Q30548452 | Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice |
| Q90625255 | Delta opioid receptors are essential to the antiallodynic action of Β2-mimetics in a model of neuropathic pain |
| Q46616130 | Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes |
| Q33764983 | Differential effects of beta-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise |
| Q41700242 | Disruption of beta3 adrenergic receptor increases susceptibility to DIO in mouse. |
| Q58553068 | Dual cholinergic signals regulate daily migration of hematopoietic stem cells and leukocytes |
| Q39749519 | ERK plays a regulatory role in induction of LTP by theta frequency stimulation and its modulation by beta-adrenergic receptors |
| Q44489669 | Effect of beta1- and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans |
| Q46323224 | Effect of targeted deletions of beta1- and beta2-adrenergic-receptor subtypes on heart rate variability |
| Q48248943 | Enhanced proliferation of astrocytes from beta(2)-adrenergic receptor knockout mice is influenced by the IGF system |
| Q37962417 | Epinephrine and the metabolic syndrome |
| Q30854338 | Epithelial Gpr116 regulates pulmonary alveolar homeostasis via Gq/11 signaling |
| Q35127294 | Exercise assessment of transgenic models of human cardiovascular disease |
| Q37502302 | Functional associations among G protein-coupled neurotransmitter receptors in the human brain |
| Q33855954 | Functional β-adrenoceptors are important for early muscle regeneration in mice through effects on myoblast proliferation and differentiation |
| Q26772221 | G-protein Coupled Receptor Signaling in Pluripotent Stem Cell-derived Cardiovascular Cells: Implications for Disease Modeling |
| Q33847602 | Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies |
| Q36943780 | Genetically changed mice with chronic deficiency or overexpression of the beta-adrenoceptors--what can we learn for the therapy of heart failure? |
| Q46894919 | Glycyrrhizic Acid Reduces Heart Rate and Blood Pressure by a Dual Mechanism. |
| Q47095418 | Gαi is required for carvedilol-induced β1 adrenergic receptor β-arrestin biased signaling |
| Q28267721 | Haematopoietic stem cell release is regulated by circadian oscillations |
| Q38304895 | Heterodimerization of β2 adrenergic receptor and somatostatin receptor 5: Implications in modulation of signaling pathway |
| Q36443015 | Hypertension, kidney, and transgenics: a fresh perspective |
| Q41555471 | IGF-1 regulates cAMP levels in astrocytes through a beta2-adrenergic receptor-dependant mechanism. |
| Q24653887 | Identification of the endophilins (SH3p4/p8/p13) as novel binding partners for the beta1-adrenergic receptor |
| Q40330829 | Imaging nanometer domains of beta-adrenergic receptor complexes on the surface of cardiac myocytes |
| Q42613659 | Impaired neoangiogenesis in β₂-adrenoceptor gene-deficient mice: restoration by intravascular human β₂-adrenoceptor gene transfer and role of NFκB and CREB transcription factors |
| Q39174364 | Impaired structural and functional regeneration of skeletal muscles from β2-adrenoceptor knockout mice. |
| Q37158023 | Inactivation of the adrenergic receptor β2 disrupts glucose homeostasis in mice |
| Q37274020 | Inhibition of leptin regulation of parasympathetic signaling as a cause of extreme body weight-associated asthma |
| Q27967859 | Inhibition of type 5 phosphodiesterase counteracts β2-adrenergic signalling in beating cardiomyocytes |
| Q35119132 | Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Giα-coupled β2-adrenoceptor signaling pathway |
| Q43436501 | Knockouts model the 100 best-selling drugs--will they model the next 100? |
| Q35867936 | Lack of β2 -adrenoceptors aggravates heart failure-induced skeletal muscle myopathy in mice |
| Q28589974 | Leptin regulation of bone resorption by the sympathetic nervous system and CART |
| Q34833218 | Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. |
| Q24539101 | Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping. |
| Q35840336 | MRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytes |
| Q28388345 | Mice lacking the β2 adrenergic receptor have a unique genetic profile before and after focal brain ischaemia |
| Q42507340 | Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart |
| Q51749399 | Moderate Continuous Aerobic Exercise Training Improves Cardiomyocyte Contractility in Β1 Adrenergic Receptor Knockout Mice. |
| Q34150128 | Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure |
| Q34140872 | Mouse models of blood pressure regulation and hypertension |
| Q47098878 | Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study |
| Q36579463 | Neurohumoral activation in heart failure: the role of adrenergic receptors. |
| Q39062830 | New and Emerging Therapies and Targets: Beta-3 Agonists. |
| Q36482115 | PKA phosphorylation of SUR2B subunit underscores vascular KATP channel activation by beta-adrenergic receptors |
| Q36484604 | Phosphodiesterase-4 blunts inotropism and arrhythmias but not sinoatrial tachycardia of (-)-adrenaline mediated through mouse cardiac beta(1)-adrenoceptors |
| Q45202872 | Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level. |
| Q49887032 | Physiological Mitochondrial Fragmentation Is a Normal Cardiac Adaptation to Increased Energy Demand |
| Q36320707 | Physiological and genomic consequences of adrenergic deficiency during embryonic/fetal development in mice: impact on retinoic acid metabolism |
| Q36867076 | Postischemic brain injury is attenuated in mice lacking the beta2-adrenergic receptor. |
| Q37307260 | Postsynaptic alpha-2 adrenergic receptors are critical for the antidepressant-like effects of desipramine on behavior |
| Q37043332 | Pressor recovery after acute stress is impaired in high fructose-fed Lean Zucker rats |
| Q41846747 | Principal role of adenylyl cyclase 6 in K⁺ channel regulation and vasodilator signalling in vascular smooth muscle cells. |
| Q44835434 | Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart |
| Q44622869 | Pulmonary surfactant secretion in briefly cultured mouse type II cells |
| Q30464844 | Redundant catecholamine signaling consolidates fear memory via phospholipase C. |
| Q37908178 | Relationships among variables and their equilibrium values: caveats of time-less interpretation |
| Q91863458 | Remodeling of Bone Marrow Hematopoietic Stem Cell Niches Promotes Myeloid Cell Expansion during Premature or Physiological Aging |
| Q46404785 | Repeated daily injections and osmotic pump infusion of isoproterenol cause similar increases in cardiac mass but have different effects on blood pressure |
| Q73361332 | Selective Regulation of Mature IgG1 Transcription by CD86 and β2-Adrenergic Receptor Stimulation |
| Q34503394 | Seven-transmembrane-spanning receptors and heart function |
| Q33706896 | Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity. |
| Q43982825 | Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the beta2-adrenergic receptor |
| Q35436140 | Stress and glucocorticoids impair memory retrieval via β2-adrenergic, Gi/o-coupled suppression of cAMP signaling |
| Q28474538 | Stress-mediated increases in systemic and local epinephrine impair skin wound healing: potential new indication for beta blockers |
| Q35470587 | Sympathetic control of bone mass regulated by osteopontin |
| Q34603843 | Sympathetic hyperactivity differentially affects skeletal muscle mass in developing heart failure: role of exercise training. |
| Q35104064 | THE ROLE OF β-ADRENERGIC RECEPTORS IN HEART FAILURE: DIFFERENTIAL REGULATION OF CARDIOTOXICITY AND CARDIOPROTECTION. |
| Q40238540 | TRIENNIAL LACTATION SYMPOSIUM: Systems biology of regulatory mechanisms of nutrient metabolism in lactation |
| Q83853960 | The Arg16Gly polymorphism of the beta2-adrenergic receptor and the natriuretic response to rapid saline infusion in humans |
| Q55452338 | The Development of Compartmentation of cAMP Signaling in Cardiomyocytes: The Role of T-Tubules and Caveolae Microdomains. |
| Q44049945 | The PDZ binding motif of the beta 1 adrenergic receptor modulates receptor trafficking and signaling in cardiac myocytes |
| Q35978071 | The PDZ-binding motif of the beta2-adrenoceptor is essential for physiologic signaling and trafficking in cardiac myocytes |
| Q34789836 | The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction. |
| Q36008573 | The beta2 adrenergic receptor regulates morphine tolerance and physical dependence |
| Q52624390 | The crosstalk between autonomic nervous system and blood vessels. |
| Q90411083 | The deubiquitinase ubiquitin-specific protease 20 is a positive modulator of myocardial β1-adrenergic receptor expression and signaling |
| Q34028374 | The role of beta(2)-adrenergic receptor variation in human hypertension |
| Q34734993 | The role of catecholamines in seizure susceptibility: new results using genetically engineered mice |
| Q27690920 | The role of ghrelin in reward-based eating |
| Q35820854 | The β2-adrenergic receptor as a surrogate odorant receptor in mouse olfactory sensory neurons |
| Q34469952 | Total beta-adrenoceptor knockout slows conduction and reduces inducible arrhythmias in the mouse heart |
| Q38302843 | Xamoterol impairs hippocampus-dependent emotional memory retrieval via Gi/o-coupled β2-adrenergic signaling |
| Q44521477 | alpha 1d Adrenoceptor signaling is required for stimulus induced locomotor activity |
| Q28139083 | beta 1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of beta 1-adrenergic receptor interaction with N-methyl-D-aspartate receptors |
| Q36013500 | beta(2)-Adrenergic receptor-dependent sexual dimorphism for murine leukocyte migration |
| Q41808403 | β 1 Adrenoceptor antagonistic effects of the supposedly selective β 2 adrenoceptor antagonist ICI 118,551 on the positive inotropic effect of adrenaline in murine hearts. |
| Q47911126 | β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer |
| Q50532122 | β2-Adrenoceptor is involved in connective tissue remodeling in regenerating muscles by decreasing the activity of MMP-9. |
| Q35609622 | β2-Adrenoreceptors of regulatory lymphocytes are essential for vagal neuromodulation of the innate immune system. |
| Q34876648 | β2-adrenergic receptor knockout mice exhibit A diabetic retinopathy phenotype |
| Q35250102 | β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways |
| Q89655637 | β2-adrenergic signals downregulate the innate immune response and reduce host resistance to viral infection |
| Q47406087 | β2-adrenergic stimulation of dendritic cells favors IL-10 secretion by CD4+ T cells |
| Q28564393 | β2AR antagonists and β2AR gene deletion both promote skin wound repair processes |
Search more.